Navigation Links
Queen's University Chooses Xceed's Ziplex(R) System for Translational Research
Date:9/15/2008

expression levels in primary follicular lymphoma were correlated with a five-year outcome. The Ziplex System will facilitate and streamline the critical next phase of our research to validate the signature. Currently there are no molecular diagnostic tools on the market that can predict which primary tumors will be aggressive. Having an easy way to accurately categorize an individual patient's risk will help clinicians determine the treatment plan that is most likely to result in a positive health outcome."

The Ziplex System is rapidly becoming the standard platform for the nation's leading institutions performing translational research. Xceed designed the Ziplex System with turnkey functionality and significant advances in automation, array format, fluidics, parallel sample processing, and analytics to minimize complexity, user interaction, and variability between users and sites.

About Xceed Molecular (http://www.XceedMolecular.com)

Xceed's vision is to advance molecular diagnostics by successfully translating novel multiplex tests into routine clinical practice and to create robust diagnostic solutions to improve disease outcomes. Our products comprise the Ziplex System for automated gene-expression analysis (available in the US and Canada for research use only), gene expression services, and pre-configured arrays -- Xpress Chips(TM). Xceed is also developing multiplexed genomic tests for the Ziplex platform, both internally and with strategic partners. Xceed's R&D and manufacturing are headquartered in Toronto, Ontario, with executive offices in Wellesley, Massachusetts.

About Queen's University (http://www.queensu.ca)

Established by Royal Charter of Queen Victoria in 1841, Queen's University was the earliest degree-granting institution in the united Province of Canada. Today, Queen's is one of Canada's leading universiti
'/>"/>

SOURCE Xceed Molecular
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
2. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
3. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
4. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
7. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
8. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
9. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
10. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
11. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... PARIS and MOUNTAIN VIEW, Calif. ... (NYSE: SNY ; EURONEXT: SAN) and the life ... collaborating to improve care and outcomes for people with ... leadership in diabetes treatments and devices with Google,s expertise ... The companies will explore how to improve diabetes care ...
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... Chicago -based Rush University Medical ... activity of escalating doses of AST-OPC1 (oligodendrocyte progenitor ... motor complete cervical spinal cord injury (SCI). This ...
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... is a one-day event geared to patients and family members, medical professionals, ... local and regional mesothelioma experts. The conference is a collaborative effort between the ...
(Date:8/31/2015)... , ... August 31, 2015 , ... The Bay ... to Veterans residing across southwest Florida by hiring more doctors and nurses and expanding ... of expanded services. , In early July, Dr. Anthony Jabre was selected to lead ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... Replacement Surgery Program at Monmouth, was one of the first doctors in the ... results of this new approach have been impressive: faster recovery, decreased immediate and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dr. Stewart Shofner ... be prevented during Amblyopia Awareness Month. Only a comprehensive eye examination can diagnose amblyopia. ... cause of visual impairment among children, affecting approximately 2 to 3 out of every ...
(Date:8/31/2015)... ... 31, 2015 , ... The dental implant and prosthetic market in the U.S. ... Dentistry. (See Press Room ) More than 30 million Americans are missing all ... increasing demand for dental implants, the National Association of Dental Laboratories (NADL) created the ...
Breaking Medicine News(10 mins):Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
... Technology Studies (InHealth) has awarded $1.7 million in grants ... Hopkins University, Northwestern University, Medical College of Georgia, Tufts ... funding allows scientists to examine the economic and social ... diseases and chronic medical conditions. , Researchers ...
... Ribbon Week Will Educate Parents about Prescription,Drug Abuse, ... designated Monday, October 27th as the first "Lock Your ... Week from October 27-31, to,raise awareness and provide parents ... Statistics show that over 3 million teens in the ...
... In light of,recent events impacting the global ... ), a publicly traded special purpose,acquisition company with ... assets being held in trust. As of October ... account at Morgan Stanley, with,Continental Transfer & Trust ...
... NEW YORK, Oct. 14 On the eve of ... a Call for,Endorsement of National Latino AIDS Awareness Day ... the commitment of the future President of,the United States ... of,Hispanics throughout the United States and Puerto Rico," stated ...
... John Price, an Influential ... for More Than 50 Years, PLEASANT HILL, Calif., Oct. 14 ... Gala on Friday, October 17, 2008 at,the Diablo Country Club located ... of community service the Y has provided,throughout Contra Costa County. One ...
... AMSTERDAM, Netherlands, Oct. 14 Doctors in,the Netherlands ... VAR ) to treat four early stage ... among the world,s first treatments of their kind. ... plan to replace,conventional stereotactic radiotherapy treatments with RapidArc ...
Cached Medicine News:Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 2Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 3Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 4Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Apex Bioventures Announces Trust Investment Details 2Health News:The Latino Commission on AIDS Call on Presidential Candidates to Honor National Latino AIDS Awareness Day on October 15 2Health News:Mt. Diablo Region YMCA to Celebrate 50 Years of Community Service at 28th Annual Boosters Gala on October 17, 2008 2Health News:Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems 2Health News:Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems 3
... new OTI-Scan 1000 is the most advanced ... B/A-scan system operates with a single Macintosh ... B-scans with a streamlined internal probe rotator. ... newly designed. The UltraFast 12 MHz B-probe ...
... The B5500 is a sensitive B-scan system ... the axial length of both eyes differ by ... ocular abnormality must be suspected. The B5500 enables ... setting up a water bath or inserting shells ...
... A-scan and B-scan system, providing accurate and ... high frequency, low noise probe and fast ... upon application of the probe along the ... length of both eyes differ by more ...
... The CineScan A/B represent a true breakthrough ... image with technology and diagnostic capability previously ... the vitreous. Adjust the gain up to ... be invisible at a standard 90db setting ...
Medicine Products: